UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
58 hedge funds and large institutions have $157M invested in Unity Biotechnology in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 57 → 58 (+1)
0.04% more ownership
Funds ownership: 3.82% → 3.86% (+0.04%)
Holders
58
Holding in Top 10
–
Calls
$76K
Puts
$4K
Top Buyers
| 1 | +$1.85M | |
| 2 | +$1.48M | |
| 3 | +$1.31M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$981K |
| 5 |
SCM
Sio Capital Management
New York
|
+$956K |
Top Sellers
| 1 | -$3.2M | |
| 2 | -$1.2M | |
| 3 | -$1.1M | |
| 4 |
Millennium Management
New York
|
-$548K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$280K |